News
Community driven content discussing all aspects of software development from DevOps to design patterns. Good programmers need to create code that efficiently solves problems, using various methods. A ...
By applying a proprietary OS to drug discovery, Recursion is turning drug discovery from sequential testing into a search problem.
Recursion has stumbled through an early test of its tech-enabled approach to drug discovery, reporting a hit on its phase 2 primary endpoint of safety and tolerability but failing to wow on the ...
Yet, while Fibonacci is a great example in recursion, more often than not, the downside to recursion isn’t addressed — that is, recursion is slower than brute force iteration.
Chris Gibson, Ph.D., Co-founder and CEO of Recursion said, “REC-1245 is a prime example of using an expansive AI-enabled platform for drug discovery. After exploring many predicted biological ...
Recursion has a library of 3 trillion searchable genes that will serve as the foundation for the company's AI-powered drug discovery program.
Iambic Therapeutics welcomed former Recursion CFO Michael Secora to its C-suite on Monday morning. Secora now becomes the chief corporate development officer and CFO at Iambic, a San Diego-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results